These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 816456)

  • 1. Laminar air flow room reverse isolation and microbial suppression to prevent infection in patients with cancer.
    Schimpff SC
    Cancer Chemother Rep; 1975; 59(6):1055-60. PubMed ID: 816456
    [No Abstract]   [Full Text] [Related]  

  • 2. Reverse isolation in bone marrow transplantation: ultra-clean room compared with laminar flow technique. II. Microbiological and clinical results.
    Vossen JM; van der Waay D
    Rev Eur Etud Clin Biol; 1972; 17(6):564-74. PubMed ID: 4630613
    [No Abstract]   [Full Text] [Related]  

  • 3. Reverse isolation in bone marrow transplantation: ultra-clean room compared with laminar flow technique. I. Isolation systems.
    Vossen JM; van der Waay D
    Rev Eur Etud Clin Biol; 1972 May; 17(5):457-61. PubMed ID: 4567425
    [No Abstract]   [Full Text] [Related]  

  • 4. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.
    Levine AS; Siegel SE; Schreiber AD; Hauser J; Preisler H; Goldstein IM; Seidler F; Simon R; Perry S; Bennett JE; Henderson ES
    N Engl J Med; 1973 Mar; 288(10):477-83. PubMed ID: 4630706
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection prevention for patients with acute leukemia using laminar air flow rooms.
    Masaoka T
    Tokai J Exp Clin Med; 1986; 11 Suppl():9-14. PubMed ID: 2837838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protected environment units for the cancer patient.
    Bodey GP; Watson P; Cooper C; Freireich EJ
    CA Cancer J Clin; 1971; 21(4):215-9. PubMed ID: 4998235
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with protective isolation for infection prevention in the compromised host.
    Nagao T
    Tokai J Exp Clin Med; 1986; 11 Suppl():23-8. PubMed ID: 3132751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.
    Schimpff SC; Greene WH; Young VM; Fortner CL; Cusack N; Block JB; Wiernik PH
    Ann Intern Med; 1975 Mar; 82(3):351-8. PubMed ID: 1054222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protected environment units in the treatment of acute leukemia.
    Preisler HD; Bjornsson S
    Semin Oncol; 1975 Dec; 2(4):369-77. PubMed ID: 824738
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient isolation units for cancer patients treated with chemical immunosuppressive agents.
    Bodey GP
    Transplant Proc; 1973 Sep; 5(3):1279-84. PubMed ID: 4199579
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of studies on protected environments and prophylactic antibiotics in adult acute leukemia.
    Levine AS; Robinson RA; Hauser JM
    Eur J Cancer (1965); 1975 Aug; 11suppl():57-66. PubMed ID: 815093
    [No Abstract]   [Full Text] [Related]  

  • 12. [The problem of infections in acute leukemias: origin, therapy and prevention by protective isolation].
    Delsignore R; Baroni MC; Rizzoli V; Quaini F; Mangoni L; Butturini U
    Ateneo Parmense Acta Biomed; 1977; 48(5):381-403. PubMed ID: 418788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protected environment--prophylactic antibiotic programmes; clinical studies.
    Levine AS
    Clin Haematol; 1976 Jun; 5(2):409-24. PubMed ID: 939058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of isolators in the treatment of acute leukemias].
    Lucarelli G; Porcellini A; Izzi T
    Minerva Med; 1975 Jul; 66(52):2612-8. PubMed ID: 807891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of infection in patients with agranulocytosis through isolation and whole-body decontamination].
    Fopp M; Gasser A; Eigenmann B; Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1975 Aug; 105(35):1123-5. PubMed ID: 808849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary studies of the effectiveness of a patient isolation unit and of prophylactic antibiotics in therapy of acute leukemia.
    Klastersky J; Cappel R; Debusscher L; Lachapelle F
    Acta Clin Belg; 1971; 26(4):191-200. PubMed ID: 5004992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Experiences with isolation of leukemic patients].
    Schäden J
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1792-4. PubMed ID: 1215983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reverse isolation of patients with blood diseases in a near germ-free environment].
    Bláha M; Mĕrka V; Vanásek J; Hrncír Z; Mazák J; Siroký O
    Z Gesamte Inn Med; 1976 Dec; 31(23):971-5. PubMed ID: 798433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of protected environment for children with malignant disease.
    Ohira M; Shibata T; Ise T
    Jpn J Clin Oncol; 1983; 13 Suppl 1():143-9. PubMed ID: 6834657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.
    Yates JW; Holland JF
    Cancer; 1973 Dec; 32(6):1490-8. PubMed ID: 4202191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.